HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids
Cancer Chemotherapy and Pharmacology1988Vol. 21(3), pp. 216–20
Citations Over Time
Related Papers
- → Epirubicin Versus Doxorubicin: Which Is the Anthracycline of Choice for the Treatment of Breast Cancer?(2003)94 cited
- → A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group.(1991)83 cited
- → Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model(1996)15 cited
- → A Skin Manifestation due to the Intraarterial Infusion of Epirubicin.(2002)
- → ΧΗΜΕΙΟΠΡΟΦΥΛΑΞΗ ΤΩΝ ΕΠΙΦΑΝΕΙΑΚΩΝ ΟΓΚΩΝ ΤΗΣ ΟΥΡΟΔΟΧΟΥ ΚΥΣΤΕΩΣ ΜΕ ΕΝΔΟΚΥΣΤΙΚΕΣ ΕΓΧΥΣΕΙΣ 4-EPI-DOXORUBICIN(1994)